SG Americas Securities LLC Purchases New Shares in Phreesia, Inc. (NYSE:PHR)

SG Americas Securities LLC acquired a new stake in Phreesia, Inc. (NYSE:PHR - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 18,069 shares of the company's stock, valued at approximately $462,000.

A number of other hedge funds have also recently added to or reduced their stakes in PHR. Johnson Financial Group Inc. grew its position in shares of Phreesia by 381.3% in the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after buying an additional 896 shares during the last quarter. BankPlus Trust Department acquired a new stake in Phreesia in the fourth quarter valued at approximately $34,000. Quarry LP increased its stake in Phreesia by 210.9% during the 4th quarter. Quarry LP now owns 2,835 shares of the company's stock valued at $71,000 after purchasing an additional 1,923 shares in the last quarter. Venturi Wealth Management LLC bought a new stake in shares of Phreesia during the fourth quarter worth about $76,000. Finally, Smartleaf Asset Management LLC increased its holdings in Phreesia by 154.6% during the 4th quarter. Smartleaf Asset Management LLC now owns 3,442 shares of the company's stock worth $89,000 after purchasing an additional 2,090 shares in the last quarter. Institutional investors and hedge funds own 92.10% of the company's stock.

Phreesia Trading Up 3.1%

PHR stock traded up $0.83 during trading on Tuesday, hitting $27.85. 601,833 shares of the company traded hands, compared to its average volume of 447,102. The company has a 50-day moving average of $25.29 and a 200-day moving average of $26.02. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.95 and a current ratio of 1.95. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $30.53. The firm has a market capitalization of $1.66 billion, a PE ratio of -37.63 and a beta of 0.68.

Phreesia (NYSE:PHR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) earnings per share for the quarter, beating the consensus estimate of ($0.13) by $0.06. Phreesia had a negative return on equity of 16.23% and a negative net margin of 9.83%. The firm had revenue of $115.94 million during the quarter, compared to the consensus estimate of $115.00 million. During the same quarter in the previous year, the company posted ($0.05) earnings per share. The business's revenue was up 14.5% on a year-over-year basis. Analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Analyst Ratings Changes

PHR has been the subject of several analyst reports. Truist Financial increased their target price on shares of Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a report on Thursday, May 29th. Canaccord Genuity Group decreased their price objective on Phreesia from $35.00 to $34.00 and set a "buy" rating on the stock in a research note on Thursday, May 29th. Wall Street Zen upgraded shares of Phreesia from a "hold" rating to a "buy" rating in a research note on Sunday, June 1st. Needham & Company LLC reiterated a "buy" rating and set a $29.00 price target on shares of Phreesia in a research report on Thursday, March 13th. Finally, KeyCorp cut their price objective on Phreesia from $30.00 to $28.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. Twelve analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Phreesia currently has an average rating of "Buy" and an average target price of $31.64.

Insider Buying and Selling at Phreesia

In other news, CFO Balaji Gandhi sold 1,827 shares of Phreesia stock in a transaction dated Wednesday, March 26th. The shares were sold at an average price of $27.46, for a total transaction of $50,169.42. Following the sale, the chief financial officer now owns 103,591 shares of the company's stock, valued at approximately $2,844,608.86. The trade was a 1.73% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, General Counsel Allison C. Hoffman sold 6,024 shares of the business's stock in a transaction dated Tuesday, April 8th. The shares were sold at an average price of $23.85, for a total transaction of $143,672.40. Following the transaction, the general counsel now owns 143,830 shares in the company, valued at $3,430,345.50. This represents a 4.02% decrease in their position. The disclosure for this sale can be found here. Insiders sold 49,630 shares of company stock valued at $1,228,707 in the last quarter. Company insiders own 5.50% of the company's stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.